The trademark application NextGenBrain was filed by Javier Ignacio ROMERO LEDESMA, a national of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on September 29, 2021, and it was registered by office on January 6, 2022 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with Media for cell culture for use in the biotechnological industry and Chemical reagents for use in biotechnology, other than for medical or veterinary use..
The mark was filed in class 5 with following description of goods:
Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes
Pharmaceuticals
Biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy
Clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing
Pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy.
The mark was filed in class 42 with following description of goods:
Consultancy relating to biotechnology
Information on the subject of scientific research in the field of biochemistry and biotechnology
Research relating to biotechnology
Research and development in the pharmaceutical and biotechnology fields
Design services relating to process systems for the biotechnology industry.